Q2 2019 Earnings Call
To the event center and event specialist will join you shortly.
If you're a speaker or presenter. Please notify the event specialist you may be asked to provide a confirmation code speakers name all the title of your event. Please be prepared to provide that information. Once you have provided that information you will be placed on hold with music or placed into your event.
Hello, and welcome to the event center and events specialist will join you shortly if you're a speaker or presenter. Please notify the event.
Thank you for calling me the confirmation code.
It's 971 to 936.
Then came in the spelling of your first and last name.
His name is Michael and my Chk he'll last name is village via I see age.
Thank you Sam a company they work for.
Aaron its A.I.E.R.A.
[noise].
<unk> Okay, great. Thank you officially made in just a moment sir.
Thank you.
You're welcome and yard and advanced materials portfolio, which was recently expanded with the acquisition of digital specialty chemicals or Dfc in March.
The deposition materials market is one of the fastest growing market segments in semiconductor applications.
Driven by the adoption of new materials in more complex chip architectures.
MPD will improve integrys.
Gail and synthesis capabilities, particularly in Orlando sailing materials.
Our existing capabilities combined with DSC and MPD will give us the technology and proven capability to effectively compete in advance nodes.
In addition, MPD will provide us access to a number of exciting adjacent markets.
NPD was acquired for approximately a $165 million in cash.
It is expected to have sales approaching $40 million for the full year of 2019 and be accretive to earnings in 2020.
NPD will be part of our CDN business.
Looking ahead to the second half of the year.
To start.
We believe the second quarter represents a bottom for entegris.
From an industry point of view memory makers are still working through inventory, but logic and foundry is solid.
But to be clear our confidence is not a bad on a significant market recovery in the second half.
Our confidence instead is based on the strength of our business.
As we discussed last quarter, we are benefiting from several important node transitions, which will drive the adoption of many new products across all three divisions.
In addition, after several quarters of weakness, we believe that we've reached an inflection point in our Capex driven products.
Which are no longer declining and now starting to see steadier order patterns.
In closing, we believe that secular semiconductor demand will continue to be attractive.
Enabled by technologies like Aiotv, Fiveg and AI, Our society will continue to need more embedded chips.
Greater materials intensity and greater materials jewelry team will be to to defining factors of the next generation of semiconductor performance.
Our unit driven business model is resilient.
Differentiated and defensible.
Integrys has never been better positioned and more relevant for customers to achieve higher yields and to targeted levels of chip performance and reliability.
As we have shown with the reorganization announced today and the recent acquisitions.
We are continually assessing and dynamically managing our portfolio to drive growth and improve returns.
And while results were challenging in the second quarter, we have continued to make the necessary capital and R&D investments in our business to enable long term growth.
Finally.
We expect 2019 to be a record year for integrity.
And we are reaffirming our annual guidance.
We expect our sales in 2019 to be approximately a billion six and we expect that both GAAP and non-GAAP EPS.
To exceed $1.90 cents.
I will now turn the call to Greg for the financial details Greg.
Thank you Bertrand our overall second quarter performance was mixed relative to our expectations Q2 sales of $379 million or at the bottom end of our sales guidance range and were down 1% from a year ago and 3% sequentially.
Q2, GAAP diluted earnings per share was 91 cents GAAP EPS included a $122 million of net proceeds we received from the terminated PERCIUM transaction.
On a non-GAAP basis EPS of 39 cents was below expectation.
Moving on to gross margins GAAP and non-GAAP gross margin were both 44% in Q2.
The year on year decline in non-GAAP gross margin was driven primarily by the addition of a pure gas business acquired from say to the portfolio lower sales volume weaker product mix and an insurance claim in the prior year that was onetime in nature.
We expect gross margin to be approximately 46% on a GAAP and non-GAAP basis in Q3, driven by higher sales volumes and improved mix.
GAAP operating expenses were 111 million and included approximately $17 million of amortization of intangible assets and other discrete charges totaling approximately $5 million.
non-GAAP operating expenses in Q2 were $90 million in line with our guidance.
We expect non-GAAP operating expenses to be $92 million to $94 million in the third quarter. The sequential increase from Q2 is primarily due to the additional opex related to MPD chemicals.
GAAP operating income was 55 million and non-GAAP operating income was $77 million.
Our GAAP tax rate was 25.9% for the second quarter and included a total of six percentage point impact in discrete items related to new tax regulations and the tax impact of diverse zoom termination payment, we expect our full year GAAP tax rate to be approximately 23%.
Our non-GAAP tax rate was 20.4% and does not include the discrete items previously mentioned.
We continue to expect our full year non-GAAP tax rate to be approximately 21%.
Adjusted EBITDA for the quarter was $95 million or 25% of revenue.
Turning to our performance by Division Q2 sales of $128 million for specialty chemicals, and engineered materials are as CEO declined 5% from a year ago.
Strong growth in advanced deposition was offset by declines in the rest of the portfolio sales trend improved from the decline in the first quarter was sequential sales up 2% in the second quarter, driven by advanced deposition specialty gases and specialty coatings.
Adjusted operating margin for at the time was 19.4% from the decline in operating margin was driven primarily by the lower sales unfavorable mix and investments in manufacturing capacity in previous quarters. In addition, and as a reminder, the second quarter last year included the benefit of a $2.5 million insurance claims.
Q2 sales of 150 million for Microcontamination control or M.C. were up 20% from last year.
The strong year on year growth in the quarter was driven by the addition of the pure gas business acquired from space.
Sales declined 5% sequentially, driven by liquid filtration, which had a record quarter in Q1 as we benefited from the initial phases of node transition.
Adjusted operating margin for FMC was 28.7%.
The modest decline from last year was primarily due to the addition of the pure gas business to the portfolio.
Q2 sales for advanced materials handling or CMH of $108 million was down 18% from last year the year over year decline in sales was driven by continued softness in capital driven businesses and the impact from the divestiture of a small noncore cleaning business last year.
Sales declined 7% sequentially as industry capital spending continued decline and we experienced weakness in sales to certain chemical customers were negatively impacted by the continued decline in memory.
Adjusted operating margin for Amazon, which was 14%.
MH margins were primarily impacted by the lower sales volumes as Bertrand indicated sales signals for our capital driven businesses have improved and that will be helpful to MH going forward.
Cash flow from operations for the second quarter was $231 million and free cash flow was $205 million, both operating cash flow and free cash flow were favorably impacted by the versum termination fee.
Uses of cash during the quarter included Capex of 26 million, we expect to spend approximately a 110 million on capex in 2019 to support new product introductions improved technical capabilities in growth in our filtration and liquid packaging businesses.
During Q2, we use 9 million for our quarterly dividend and we repurchased 400000 shares for approximately 15 million at an average price of $36.
As per Tran set up earlier I'd like to spend a few minutes to layout more formally than we've done in the past our capital allocation principles.
Over the last six years, we've allocated approximately $3 billion of capital, including investing 640 million in the R&D with the goal of growing the business and returning cash to shareholders.
To start I'd like to lay out a few principles on our liquidity and capital structure, which is intended to ensure our financial flexibility, while retaining sufficient firepower for potential opportunistic acquisition.
We target a minimum cash balance of approximately $200 million globally, and a debt rating of VA salon or better.
Going forward our capital allocation priorities are the following the first priority is internal investments in R&D and Capex. The second priority is value accretive acquisitions, the third priority as return of capital in the form of dividends and share buybacks.
Let's look at each of these more closely.
Internal investments in R&D and Capex has been a key component to our growth and generate very good returns historically.
All R&D and Capex are decided upon and prioritize based on rigorous ROI analysis.
On an ongoing basis, we would expect to continue investing approximately 8% of our annual sales in R&D and 7% in Capex.
Acquisitions have historically been the largest area of capital allocation for us and has been a key component of our growth.
As shown with the acquisition of MPD, we will continue to be active in M&A and intend to be a consolidator in the industry.
Our overall criteria are acquisitions that broaden our technology and product portfolio in our core semiconductor market and other adjacent markets.
Specifically within the scope of engineered materials filtration technology and advanced packaging.
Our targeted financial criteria for acquisitions include.
Accretion by year, two that is greater than we could achieve through buybacks or debt reduction high single digit ROI, the by year, three and growth enabling capabilities our market expansion.
The third priority is return of capital with dividends and share buybacks.
Our target is to return 60% of our annual free cash flow to shareholders through dividends and buybacks.
For dividends, we intend to pay an ongoing dividend with incremental increases as free cash flow warrants.
For share repurchases historically, we have targeted at approximately $10 million per quarter of ongoing repurchases going forward, we expect repurchases to be approximately $15 million per quarter. As we did in Q2. In addition, we will continue with opportunistic buyback like we did at the end of last year when appropriate.
Naturally these capital allocation parameters could change depending on the level of acquisition activity.
Turning to our outlook for Q3. This return onset we expect the Q2 represents the bottom for Entegris.
And we expect Entegris specific drivers will allow us to outgrow the market in the second half.
On margins, we expect sequential improvement to come primarily from higher sales volumes.
Improved mix better execution and the start of realization of cost reductions associated with the organizational changes discussed earlier.
Putting it all together in Q3, we expect sales to range from $385 million to $400 million and we expect GAAP EPS to be 29 to 34 cents per share and non-GAAP EPS to be 42 to 47 cents.
In summary, we continue to be confident with respect to the industry and our own prospects for the future.
Operator, we'll now take questions.
Thank you.
Thanks.
Thanks, Jason.
Please turn to slide.
Hi, guys I wanted to ask a question.
Hi, everyone an opportunity to signal for questions.
We will now take our first question from.
With Goldman Sachs. Please go ahead.
Hi, good morning, guys.
Good morning.
I had three if I may 1st.
In terms of the.
Operating model improvements that you guys talked about.
I was hoping you could elaborate a little bit more in terms of what you're doing exactly.
Perhaps by segment or product line to the extent possible and kind of the split between Cogs and Opex.
But that would be my first question. Thanks.
Yes, it's just the sheer let me give you maybe a high level.
Context for what we're trying to do here, which is we.
On the broad strategic initiatives that we started in the fall of last year.
And that we put on hold during the merger discussions those so.
As a company, we always looking at ways to improve our operational efficiency improve our customer intimacy.
And what do we really want to do is to make sure that we can.
Find ways to reduce our time to solution.
And ways to more closely align our development and engineering teams.
With our customer facing teams so.
Well you should expect actually.
The reorganization to have.
An impact across multiple financial statement lines.
Most notably in SGN a.
But it will really impact.
Each of the three divisions.
And the whole idea behind that again is to me because.
More responsive to customers more competitive.
And also.
Below is to be more effective in integrating future acquisitions.
Got it. Thank you and then my second question is on the second half outlook.
Bertrand you talked about.
Setting pretty conservative assumptions for.
The broader market and more more kind of relying on company specific drivers and I think thats consistent with what you had said.
Three months ago, but curious what sort of assumptions have you embedded in your second half numbers or your full year guide.
Both in terms of wafer starts as well as capex in the second half.
Perhaps relative to the first half and then more on the Companys specific stuff.
If you can remind us.
What what the what the goals are.
In terms of some of the some of the product lines that you talked about three months ago like graphite.
Specialty coatings some of the node transitions that your customers things like that thank you.
Yes, So let me start with somebody industry assumptions that we use for the second half of the year. In this said we are using what I think is it set a fairly conservative assumptions we expect.
Mm side to be flat.
In the second half of the year versus the first half.
We expect Capex to continue to slide.
And to put that in a quantitative form I would say capex down probably another 9% in the second half versus the first half. So a lot of the growth that we expect to generate in the back end of the year.
We'll come from node transition.
And.
We have felt a little bit of that already in Q1 of this year.
We expect to see actually additional momentum in logic and foundry in the back end of the year. We also expect to see the benefit of a number of memory customers transitioning to additional they use in the backend of the year. So the impact will be felt.
Mostly in Microcontamination SCM and as you mentioned, it's going to be specialty coating disposition material.
Selective.
Edge chemistry as well.
As well as.
Advanced liquid filtration solutions.
Great and then my last one in terms of some of the geographical information that you get out in your in your deck.
I was I was positively surprised by how.
Korea kind of hung and then I was negatively surprised by how weak Taiwan was in Q2 on a sequential basis I would have thought given customer commentary in memory I would have expected weaker performance in Korea, and then on the flip side given the largest foundry customers comments into Q3, I would have expected better trends in Taiwan. So if you could kind of comment on both regions. What went on during the quarter and what the outlook was into the second half. Thank you. That's all I had sure.
Sure.
So, let's start with Korea Korea sequentially good performance.
We saw.
A stabilization of level of activity in the memory fab. So no further deterioration, which was good and we picked up actually some activity on new fab construction in Korea.
So thats really what explains the.
Due to the relatively good performance in Q2, given given the overall industry context.
We expect the picture to continue to improve in the back end of the year as we expect.
Some modest improvement.
Inside of activity in memory in Korea.
In the case of Taiwan, If you look at the first half performance we are growing.
Actually 6% organically in Taiwan first quarter of this year compared to first quarter of last year. So.
So thats what I would have expected we knew that we benefited from a number of unusually high orders in Q1 related to a number of ramps and tape out activity.
And as we said in the.
Q1 results we.
We were expecting a softening in microcontamination, particularly sequentially and we saw that in Taiwan.
On the going forward in Taiwan, we expect a big Reacceleration in the back end of the year and we expect Taiwan to have a very very solid year for us.
Great. Thanks, so much for the detail.
Okay.
We will now take our next question from Sidney Ho with Deutsche Bank. Please go ahead.
Great. Thank you and good morning.
My first question is I appreciate you reaffirmed your full year guidance of $1.6 billion. So based on your Q3 guidance. It would imply that true pretty healthy rebound of sales in Q4 of at least 10% EPS of 55% of more.
Can you maybe walk us through I know you talk about Q3 dynamics, but what exactly driving the Q4 growth.
Growth assumptions there.
So sitting there were no would probably reiterate whatever it's just.
Saying and swing so she has a question.
It's all about the node transitions, we expect additional momentum coming from that both in logica was as well as in memory.
That will.
Primarily impact positively the microcontamination an as yet.
Businesses and you should expect.
Sequential increase or increases in Q3 than in Q4 for both of those divisions.
Okay. That's helpful.
Maybe switching to.
The gross margin.
The gross margin obviously in Q2 was a little little challenging.
And I think you guys talk about the year over year decline I, just try to understand the quarter over quarter.
Decline as well and is that does that kind of seen across the different segments.
And.
Related to that Q3 is going to back to 46%.
What's driving the recovery of that on a sequential basis.
Yes, I can let Greg potentially.
Add some more financial.
Details to your question, but.
Before he does that I'd like to provide maybe some high level perspective and.
What.
I want you to appreciate is that.
Sometime halfway into the quarter, So say mid to late May we realize that.
The environment would be a little bit softer than expected.
And then we also realize that the mix would not be very favorable in Q2.
So in other words, we realized in May that we would most likely testing the low end of our EPS guidance. So.
As a management team.
We.
We looked at our options, we considered slamming the brakes.
But in the end, we decided not to do that.
And instead, what we tried to do is really to curb some discretionary spending but again, we chose not to really flex down.
The labor costs as DNA or R&D.
And I really think it was the right decision. So why was that the right decision wealth.
First if you think about margin and cost of goods sold.
We were getting in May and options today, we even have further evidence that the back end of the year will be very strong for integra. So.
We felt that it would have been very foolish.
To flex down our direct labor.
In the plants in Q2, only to have to rehire and retrain.
Workers a few months later.
So thats the way I would answer your your gross margin question, but to extend my comment to other.
Parts of the PNNT I would say that.
We also chose to.
Continued to spend in R&D I mean, our development teams have been working very closely with customers.
On a number of promising opportunities.
And it was very important for us too low.
Proper funding both in Capex and in R&D, which we did.
In order to continue to increase the quality of the opportunity pipeline. So.
Not no.
Don't get me wrong, it's not pleasant not to deliver on the on an EPS number and to be slightly below the guidance.
But in this particular instance.
It wasn't calculated choice and I think it was the right choice.
Yeah, and Thats engineer.
Follow up your question.
The decline really was.
Across divisions, our volumes were down.
In two of the three divisions and then the third the third division what should be FCM, where volumes were up.
We were impacted more by mix.
Okay.
Great. Thanks, Thanks for the color Thats great.
Maybe one last question for me in terms of the.
The MPD chemicals acquisition, how much should we expect the revenue contribution from from them in Q3, and Greg When you talk about the accretion next year, what magnitude of accretion or youre kind of expecting thanks.
Yeah. So we'd expect next during Q3, we expect.
Revenues in a in the high single digits, we don't own it for the whole of food on it for the whole of the quarter and when we think about accretion next year, we think about kind of five to 10 cents per share.
Great. Thank you very much.
Once again, if you find that or if you find that your question has been answered you married yourself from the queue by pressing star too and if he would like to ask a question. Please signal by pressing star one we will now take our next question from Amanda Scarnati with Citi. Please go ahead.
Hi, good morning.
Wanted to talk a little bit about the China business. It looked like it was up quite a bit in the second quarter, but I've been hearing a lot lately. The child is increasingly tying subsidies are incentivizing subsidies to use sort of non U.S. suppliers or have you been seeing any of that in the market and sort of what drove that strong growth in China. This quarter.
Yes, good morning, Amanda So let me just say that sell businesses. So it's not really been.
Directly impacted by any of the trade tensions or export restrictions.
And.
We don't expect that to be the case going forward, so what what what drove the.
Nice sequential growth is really.
You know a number of new wins.
Actually some of our large Chinese.
Domestic.
SAP customers. So very very pleased to see that we've been able to find ways to continue to engage.
With domestic.
Chinese customers and continue to win.
New business in spite of being a U.S. suppliers. So I agree with you that there is a long term risks that you characterize that.
Some of the Chinese SAP customers may choose to lessen their reliance on us suppliers, but as of right now we have not seen any of that in fact meaningfully our business.
And then just going back to the.
Margin question as you sort of work through your due diligence with diverse Xoom acquisition.
Did you notice anything different in how they approach margins and different ways in which you can sort of expand your EBITDA margins I know you talked about a little bit of restructuring that you are doing.
But was there anything in there that that could be something longer term that you could marketing yard your model.
I mean, Amanda we I think we've implied before we certainly learned things that from a competitive perspective that around sort of business process an organization, adding some of what we announced today in Bertrand has already talked about would be a by product of that as it relates to the gross margin specifically.
I would say, we didnt really learn anything specific and then when you I feel good about how we execute and how we manage our gross margin line in a more specifically how our team manages the supply chain in the factories.
Great. Thank you.
We will now take our next question with Chris.
Chris Kapsch from <unk>.
Loop capital markets. Please go ahead Sir.
Okay.
Yeah good morning.
I just had a really a follow up on the formal comments that Bertrand you had about sort of.
Witnessing an inflection of sorts for stabilization of orders I'm just wondering if you could.
Characterize that.
By either fab.
Foundry logic memory.
Just any sort of characterization about.
Why do you feel that there is some evidence of inflection any sort of color around that.
I have one follow up.
Yes.
So the D. usually does.
The greater level of visibility that we have is directly related to two dose node transitions.
So.
And we are seeing that in advanced logic and foundry and in advanced memory.
The other area, which was actually a very important second is that we've been waiting to see if any capex driven business and across all of our.
Capex driven business lines.
We are actually seeing very very healthy.
Book to Bill ratios and that's the first time in innovate on time. So in other words, we believe that we are no longer trying to catch a falling knife on that part of our business and that gives us.
A lot more comfortable for what's ahead.
Okay. That's helpful. And then just the follow up is on the sequential rebound that you're suggesting you see in margins and maybe your your the answer to my other question sort of explains that but.
Is it just a function of the node transition is driving demand for advanced products is helping margins sequentially and continued weakness and some of the equipment side or if you could just provide some color there. Thank you.
On the yen is a sequential improvement in the margin really for us as we expect.
Things to turn return to a more normalized level in terms of both mix and we expect.
Some moderate increase in the volume so if you look at.
If you look over the last six quarters or so I mean, we've been right with the exception of early last year, where we had some paint margins we've been right at about 46% Theres nothing systemic on the margins. Our ASP trends are good we continue to execute well so it really boils down to continuing to see some improvement in mix is better volumes.
Okay. Thank you.
We will now take our next.
Hi, Patrick Ho with Stifel. Please go ahead.
Thank you very much maybe first for you, but it's Ron in terms of the.
The the materials or intensity for logic and foundry, it's clear that their new device structures. The HSCT. The smaller line, which are driving more materials engineering can you give a little bit of color, whether you're seeing new materials, you said, either advanced deposition etch and areas like that.
It's just that the content of four existing materials has increased.
At some of these new node shrinks.
So Patrick this is actually we're seeing both we are seeing greater inventory its intensity as a result of greater gate density into new architectures.
But we also amended material intensities also defined by the introduction of new highly engineered materials.
Thats is certainly an area, where we see growth.
Far exceeding the industry growth.
This is an area, where we have the objective of establishing integrity is as the leading supplier and that's really what has led us to the acquisition of DLC and NPD. We wanted to increase our capabilities in that area. We wanted to have access to high volume manufacturing synthesis capabilities. We wanted to take greater control on our supply chain, we wanted to be in a position to purify the materials that.
We are supplying to our customers and really have offered to our customers is they complete.
A series of capabilities from sentences to purification and delivery of those materials, all of which present downtick challenges that I believe integrys will be uniquely positioned to solve so again, what we're seeing.
On the logic side of things in terms of industry roadmap is very very exciting.
What we're seeing on the memory side is also equally exciting and that's why we're so focused on those opportunities.
Right that's helpful and maybe Greg as my follow up question in terms of R&D investments.
Can you make.
Strong play on that front, which has led to a lot of the new products that are now starting to pay dividends. How do you look at R&D spent cleaning up over the next year or so in terms of I guess future product developments and opportunities that are still forthcoming with future years.
Particularly on the material side of things.
Yes. So first first of all I would just say on the R&D.
All of our.
Any project of any significance has an ROI attached to it and I mean, it's a very sort of analytically driven approach in terms of where we invest our E. R&D dollars I think I said as part of the capital allocation discussion I mean, we were at 8% of.
Revenue in the most recent quarter, we've been trending sort of around that 7% level, our commitment going forward is to be in that.
Eight ish range. So if you look at our Opex year over year, I mean, we've been pretty consistent on the R&D front I mean in terms of that's the life blood of the company. So I think you can expect us to continue to continue to prioritize spending on the R&D, even as we make adjustments in other areas.
Right.
We will now take our next question from David Silver with C.L. King. Please go ahead.
Yeah, Hi, thanks very much.
I guess a couple of questions first one would just be kind of on a base for a baseline to Bertrand you or were you mentioned that you expect the second half of 2019 to be flat sequentially with the first half in terms of.
Mm hi.
I don't recall, but could you just clarify what your expectations are for the first half in other words, what what the baseline.
For the first half might be whether it's on M.S.I. or.
Wafer starts or whatever you consider the relevant metric. Thanks.
Right. So so the first half of <unk>.
19, compared to the first half of <unk>.
18, Emmis I was down about 2% as for our estimates.
And Capex.
It was down about 12% as per our estimates.
Is that your question David.
Yeah, Yeah, just wondering how you're looking at the market. So thanks. Thank you for that clarification and then the second thing I gave you.
Excuse me go ahead.
No and so I was just maybe trying to.
Provided slightly different perspective on our full year.
2019 guidance I mean, we are.
Assuming strong industry headwinds to the tune of.
Minus 8% year over year, so 19 over 80.
And you get there with.
The assumption that Capex will be down in the high teens year over year, and Emmis I, we'd be down.
3% to 4% year over year so.
To offset that we expect to pick up about 600 basis point from.
A number of acquisitions that we did.
Over the last 12 months.
And then we expect to generate about 500 basis point of organic growth in excess of the industry.
So.
So the only thing Thats changed really between this quarter and last quarter is the view that the market and the industry is probably a little bit weaker than we were.
Estimating a few months back.
Well no that's interesting and just a quick follow up but the 500 basis points of.
Organic growth above the market baseline that that's higher than your traditional.
Targets I guess your longer term targets for your overall business mix curve is that correct.
That's correct, our long term target would be two to 300 basis points over the industry. We expect we will be actually beating that target, which is something you would expect us to do given the number of new transitions that we are seeing this year.
Yes.
Okay. Thank you for that was to more than I anticipated appreciate it.
I wanted to ask a quick question maybe for Greg.
And I hope from.
Not too confusing, but you laid out your M&A criteria, very clearly and I wanted to focus on.
Accretion with this year's two acquisitions, I guess digital and.
MPB and to more than 200 million of Capex and ER sorry of.
Expenditure and.
You know.
I'm, assuming or should I assume that the combination of those two will be.
Accretive over the next 12 months and then I'm also would ask you to maybe parse the.
20 million of cost savings in other words with the acquisitions be accretive Act.
The the implementation of the 20 million in annualized cost savings or is that inclusive I mean in other words is there a little double counting their two dozen.
A portion of the anticipated.
Efficiencies come from integrating MPD and digital or is it more broad based and they would be accretive and meet your targets on a standalone basis. Thank you yeah, they're they're they're they're really two very kinda discrete events or projects so to speak.
With regard to MPD and we've got the only other question a little bit earlier, and we said five to 10 cents accretive in 2000.
And 20.
I'm, sorry, and we didn't and we waited and waited expanding DSC is a much smaller transaction, we would expect that to be accretive in 2020 as well.
Alright, thanks very much.
I will now be taking our last question from Krish Sankar with Cowen and company. Please go ahead.
Yes, hi, Thanks for taking my question I had a few of them first one blood crime. These days.
Break out your revenue by by end customer type like D, then and logic et cetera.
No we don't do that with a very high degree of precision we have given some directional color.
Perspective to that but but we don't do that on a quarterly basis.
Got it got it that's fine and then how much of the weakness you saw in Q2 was related to some won't feel a memory customer throttling back wafers.
So it wasn't really coming from.
From our memory customers directly, but we saw some in direct impact.
From their supply chains, particularly.
Both chemical manufacturers is lowering their their production levels and that had an impact on both.
Our pure drums, and Thats MH, but also sales of some liquid filters and that would be AMC. So don't the end thats something that we are not really.
Probably well forecasted going into Q2.
Got it got it and then the last question Bertrand.
Some of your customers memory customers are talking about moving.
Vapors from DRAM into Cmos image sensors, if they do such a thing is that good bad or is it agnostic for entegris.
I think it's you know it's a case by case.
And so and I wouldn't want to go into customer specifics, but I'll.
You should not be worried about about those types of offers.
Got it thank you very much.
Thank you. Thank you.
That is all the time, we have for questions I'd like to turn the conference back over to the presenters for any.
[laughter] that'll be it for today. Thank you for joining the call have a great day.
This concludes today's call. Thank you for your participation you may now disconnect.